Soria J - Search Results

1

Aggregation of chymotrypsin-treated thrombasthenic platelets is mediated by fibrinogen binding to glycoproteins IIb and IIIa.

Niewiarowski S, Kornecki E, Hershock D, Tuszynski GP, Bennett JS, Soria C, Soria J, Dunn F, Pidard D, Kieffer N, et al. Niewiarowski S, et al. Among authors: soria j, soria c. J Lab Clin Med. 1985 Dec;106(6):651-60. J Lab Clin Med. 1985. PMID: 2999274

2

Interactions of platelets with standard heparin and low molecular weight fractions.

Dunn FW, Soria C, Thomaidis A, Soria J, Dupuy E, Bellucci S, Tobelem G. Dunn FW, et al. Among authors: soria j, soria c. Nouv Rev Fr Hematol (1978). 1984;26(4):249-53. Nouv Rev Fr Hematol (1978). 1984. PMID: 6089103

3

In vivo effect of ticlopidine on fibrinogen-platelet cofactor activity and binding of fibrinogen to platelets.

Dunn FW, Soria J, Soria C, Thomaidis A, Lee H, Caen JP. Dunn FW, et al. Among authors: soria j, soria c. Agents Actions Suppl. 1984;15:97-104. doi: 10.1007/BF01966985. Agents Actions Suppl. 1984. PMID: 6091425 No abstract available.

4

Fibrinogen binding on human platelets. Influence of different heparins and of pentosane polysulfate.

Dunn F, Soria J, Soria C, Thomaidis A, Tobelem G, Caen JP. Dunn F, et al. Among authors: soria j, soria c. Thromb Res. 1983 Jan 15;29(2):141-8. doi: 10.1016/0049-3848(83)90135-4. Thromb Res. 1983. PMID: 6189236

5

[The biology of fibrinogen. The role of pentoxifylline].

Soria J, Soria C. Soria J, et al. Among authors: soria c. J Mal Vasc. 1989;14 Suppl A:25-8. J Mal Vasc. 1989. PMID: 2654312 Review. French.

6

Platelet aggregation occurs in congenital afibrinogenaemia despite the absence of fibrinogen or its fragments in plasma and platelets, as demonstrated by immunoenzymology.

Soria J, Soria C, Borg JY, Mirshahi M, Piguet H, Tron P, Fessard C, Caen JP. Soria J, et al. Among authors: soria c. Br J Haematol. 1985 Jul;60(3):503-14. doi: 10.1111/j.1365-2141.1985.tb07447.x. Br J Haematol. 1985. PMID: 3893523

7

[Familial dysfibrinogenemia with abnormal nonomer aggregation. Paris III fibrinogen].

Soria J, Soria C. Soria J, et al. Among authors: soria c. Pathol Biol (Paris). 1974 Nov;22 suppl:72-9. Pathol Biol (Paris). 1974. PMID: 4620099 French. No abstract available.

8

Reversible translocation of glycoprotein Ib in plasmin-treated platelets: consequences for platelet function.

Lu H, Soria C, Soria J, De Romeuf C, Perrot JY, Tenza D, Garcia I, Caen JP, Cramer EM. Lu H, et al. Among authors: soria j, soria c. Eur J Clin Invest. 1993 Dec;23(12):785-93. doi: 10.1111/j.1365-2362.1993.tb00732.x. Eur J Clin Invest. 1993. PMID: 7511534

9

[Fibrinogen, a vascular risk factor].

Caen JP, Soria J, Collet JP, Soria C. Caen JP, et al. Among authors: soria j, soria c. Bull Acad Natl Med. 1993 Nov;177(8):1433-41; discussion 1441-4. Bull Acad Natl Med. 1993. PMID: 8193948 French.

10

Determination of fibrinogen degradation products by immuno-enzymological assay.

Soria J, Soria C. Soria J, et al. Among authors: soria c. Thromb Res. 1978 Jun;12(6):1025-35. doi: 10.1016/0049-3848(78)90058-0. Thromb Res. 1978. PMID: 358481 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,378 results

Search Page

Filters